These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21309431)

  • 1. Hepatitis C virus infection: risk factors, diagnosis and management.
    Pears E
    Nurs Stand; 2010 Dec 15-2011 Jan 4; 25(15-17):49-56; quiz 58. PubMed ID: 21309431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus.
    Jarrett M; Cox P
    Nurs Clin North Am; 2004 Mar; 39(1):219-29. PubMed ID: 15062738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic hepatitis C: apart from antiviral treatment what other measures should be recommended?].
    Larrey D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B283-90. PubMed ID: 12180302
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of recurrent hepatitis C after liver transplantation: a concise review.
    Szabo G; Katz E; Bonkovsky HL
    Am J Gastroenterol; 2000 Sep; 95(9):2164-70. PubMed ID: 11007212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the management of hepatitis C.
    Vakil D; McCaughan G
    Aust Fam Physician; 1998 Sep; 27(9):780-6. PubMed ID: 9769524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hepatitis C virus: the first decade.
    Poynard T
    Semin Liver Dis; 2004; 24 Suppl 2():19-24. PubMed ID: 15346242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the community nurse in hepatitis C diagnosis and treatment.
    Poll R
    Br J Community Nurs; 2009 Jul; 14(7):292, 294-6. PubMed ID: 19597380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
    Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
    Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis C. Treatment and side effect management.
    Lee SP
    Adv Nurse Pract; 2003 Jul; 11(7):73-8. PubMed ID: 12886741
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequency of depression and somatic symptoms in patients on interferon alpha/ribavirin for chronic hepatitis C.
    Shakoor A; Shafqat F; Mehmud Te; Akram M; Riaz S; Iqbal Z; Khan AA
    J Ayub Med Coll Abbottabad; 2010; 22(4):6-9. PubMed ID: 22455250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy.
    Giannini EG; Marenco S; Fazio V; Pieri G; Savarino V; Picciotto A
    Liver Int; 2012 Aug; 32(7):1113-9. PubMed ID: 22471814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I favor therapy for hepatitis C virus recurrence after transplantation.
    Samuel D
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S55-8. PubMed ID: 12362300
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon treatment of children with chronic hepatitis C.
    al-Tawil Y; Nelson C
    Hepatogastroenterology; 1998; 45(20):345-8. PubMed ID: 9638404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis C treatment without liver biopsy].
    Siboni A
    Ugeskr Laeger; 2002 Mar; 164(11):1522-3; discussion 1523-4. PubMed ID: 11924484
    [No Abstract]   [Full Text] [Related]  

  • 16. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.
    Yalcin K; Degertekin H; Yildiz F; Kilinc N
    J Gastroenterol; 2003; 38(8):796-800. PubMed ID: 14505137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis.
    Tran HA; Malcolm Reeves GE; Gibson R; Attia JR
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1163-8. PubMed ID: 19682190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
    Fernández I; Ulloa E; Colina F; Abradelo M; Jiménez C; Gimeno A; Meneu JC; Lumbreras C; Solís-Herruzo JA; Moreno E
    Liver Transpl; 2009 Aug; 15(8):948-55. PubMed ID: 19642125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study.
    Pavlović Z; Delić D; Marić NP; Vuković O; Jašović-Gašić M
    Psychiatr Danub; 2011 Dec; 23(4):370-7. PubMed ID: 22075738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.